DeGregorio Mw

No ORCID on file · 2 papers in corpus
lab-animal 2017
Menopause (New York, N.Y.) ·doi:10.1097/gme.0000000000000776

OBJECTIVE: Ospemifene, an estrogen receptor agonist/antagonist approved for the treatment of dyspareunia and vaginal dryness in postmenopausal women, has potential new indications as an immune modulator. The overall objective of the present…

review 2013

Lin H Soe, Gregory T Wurz, Chiao-Jung Kao, Michael W DeGregorio Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA Abstract: Ospemifene is a selecti…